share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

SEC ·  Nov 21 05:33

Summary by Futu AI

Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, completed a purchase of 299,238 shares of common stock on November 18, 2024. The transaction was carried out at a price of $0.0919 per share, resulting in a total investment of approximately $27,489. The acquisition was made directly and increased Chiavacci's total holdings in the company to 351,510 shares. This transaction reflects a significant buy-in by Chiavacci, signaling potential confidence in the future of Conduit Pharmaceuticals.
Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, completed a purchase of 299,238 shares of common stock on November 18, 2024. The transaction was carried out at a price of $0.0919 per share, resulting in a total investment of approximately $27,489. The acquisition was made directly and increased Chiavacci's total holdings in the company to 351,510 shares. This transaction reflects a significant buy-in by Chiavacci, signaling potential confidence in the future of Conduit Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated